U.S. Markets open in 8 hrs 20 mins

Bio-Rad Laboratories, Inc. (BIO)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
217.77-2.59 (-1.18%)
At close: 4:00PM EDT
People also watch
BRKRQGENCRLPKIWAT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue2,068,1722,019,4412,175,044
Cost of Revenue930,085897,771996,527
Gross Profit1,138,0871,121,6701,178,517
Operating Expenses
Research Development205,864192,972220,333
Selling General and Administrative816,724761,990808,200
Non Recurring62,30562,30562,305
Others---
Total Operating Expenses---
Operating Income or Loss53,194166,708149,984
Income from Continuing Operations
Total Other Income/Expenses Net10,3088313,704
Earnings Before Interest and Taxes63,502167,539153,688
Interest Expense21,94221,69222,131
Income Before Tax41,560145,847131,557
Income Tax Expense13,43532,75442,712
Minority Interest---
Net Income From Continuing Ops28,125113,09388,845
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income28,125113,09388,845
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares28,125113,09388,845